Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

	Abstract	Full	Pdf
Sep 2022	640	650	145
Oct 2022	362	373	126
Nov 2022	169	170	60
Dec 2022	137	137	45
Jan 2023	165	165	68
Feb 2023	140	141	54
Mar 2023	113	113	56
Apr 2023	97	98	43
May 2023	92	92	41
Jun 2023	89	89	38
Jul 2023	81	81	49
Aug 2023	57	57	29
Sep 2023	49	49	29
Oct 2023	52	52	35
Nov 2023	47	47	24
Dec 2023	48	48	33
Jan 2024	64	65	46
Feb 2024	60	60	36
Mar 2024	72	72	87
Total	2534	2559	1044